Ocean Biomedical IncNASDAQ:OCEA
- LAST PRICE1.2550
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.2600/ 2
- Ask / Lots1.3500/ 7
- Open / Previous Close1.4200 / 1.2550
- Day Range
- 52 Week Range
- Volume170,259
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OCEA |
|---|---|---|
| 09:32 ET | 10584 | 1.44 |
| 09:36 ET | 5333 | 1.4 |
| 09:38 ET | 200 | 1.39 |
| 09:39 ET | 942 | 1.3605 |
| 09:41 ET | 3688 | 1.36 |
| 09:43 ET | 337 | 1.366 |
| 09:45 ET | 500 | 1.36 |
| 09:48 ET | 387 | 1.36 |
| 09:50 ET | 11000 | 1.34 |
| 09:52 ET | 200 | 1.32 |
| 09:54 ET | 200 | 1.31 |
| 09:56 ET | 400 | 1.31 |
| 09:57 ET | 2700 | 1.3 |
| 09:59 ET | 750 | 1.32 |
| 10:01 ET | 533 | 1.305 |
| 10:03 ET | 200 | 1.3 |
| 10:06 ET | 100 | 1.3 |
| 10:08 ET | 100 | 1.3 |
| 10:10 ET | 200 | 1.3 |
| 10:12 ET | 2462 | 1.34 |
| 10:21 ET | 100 | 1.32 |
| 10:24 ET | 208 | 1.32 |
| 10:32 ET | 100 | 1.32 |
| 10:33 ET | 1400 | 1.31 |
| 10:35 ET | 100 | 1.31 |
| 10:42 ET | 350 | 1.32 |
| 10:44 ET | 100 | 1.315 |
| 10:46 ET | 857 | 1.31 |
| 10:50 ET | 167 | 1.315 |
| 10:51 ET | 3403 | 1.32 |
| 10:53 ET | 100 | 1.32 |
| 10:55 ET | 800 | 1.32 |
| 10:57 ET | 200 | 1.32 |
| 11:00 ET | 300 | 1.32 |
| 11:02 ET | 2102 | 1.33 |
| 11:04 ET | 550 | 1.3454 |
| 11:06 ET | 100 | 1.33 |
| 11:11 ET | 100 | 1.33 |
| 11:18 ET | 100 | 1.33 |
| 11:38 ET | 208 | 1.32 |
| 11:44 ET | 3400 | 1.315 |
| 11:45 ET | 200 | 1.32 |
| 11:51 ET | 200 | 1.315 |
| 11:54 ET | 200 | 1.315 |
| 11:56 ET | 835 | 1.315 |
| 11:58 ET | 1580 | 1.315 |
| 12:00 ET | 100 | 1.315 |
| 12:03 ET | 240 | 1.3196 |
| 12:05 ET | 100 | 1.315 |
| 12:07 ET | 100 | 1.315 |
| 12:09 ET | 100 | 1.315 |
| 12:16 ET | 200 | 1.315 |
| 12:23 ET | 760 | 1.3197 |
| 12:25 ET | 100 | 1.315 |
| 12:30 ET | 200 | 1.315 |
| 12:32 ET | 100 | 1.315 |
| 12:43 ET | 100 | 1.315 |
| 12:45 ET | 500 | 1.3184 |
| 12:48 ET | 2298 | 1.315 |
| 12:50 ET | 1439 | 1.31 |
| 12:52 ET | 1395 | 1.305 |
| 12:54 ET | 100 | 1.305 |
| 12:56 ET | 100 | 1.305 |
| 12:57 ET | 600 | 1.3 |
| 12:59 ET | 400 | 1.305 |
| 01:01 ET | 100 | 1.305 |
| 01:03 ET | 1800 | 1.305 |
| 01:06 ET | 2250 | 1.305 |
| 01:08 ET | 4735 | 1.305 |
| 01:12 ET | 233 | 1.305 |
| 01:14 ET | 3652 | 1.28 |
| 01:15 ET | 2900 | 1.285 |
| 01:17 ET | 2033 | 1.275 |
| 01:19 ET | 348 | 1.275 |
| 01:21 ET | 520 | 1.2795 |
| 01:24 ET | 100 | 1.275 |
| 01:26 ET | 394 | 1.275 |
| 01:28 ET | 200 | 1.275 |
| 01:30 ET | 1170 | 1.275 |
| 01:32 ET | 100 | 1.275 |
| 01:33 ET | 200 | 1.275 |
| 01:35 ET | 200 | 1.275 |
| 01:37 ET | 100 | 1.275 |
| 01:39 ET | 2670 | 1.275 |
| 01:42 ET | 100 | 1.275 |
| 01:44 ET | 100 | 1.275 |
| 01:46 ET | 314 | 1.275 |
| 01:48 ET | 600 | 1.2799 |
| 01:57 ET | 300 | 1.2799 |
| 02:00 ET | 100 | 1.275 |
| 02:04 ET | 120 | 1.2738 |
| 02:06 ET | 500 | 1.2799 |
| 02:09 ET | 1200 | 1.275 |
| 02:11 ET | 1100 | 1.2701 |
| 02:13 ET | 1500 | 1.275 |
| 02:15 ET | 500 | 1.275 |
| 02:18 ET | 100 | 1.275 |
| 02:20 ET | 100 | 1.275 |
| 02:22 ET | 100 | 1.275 |
| 02:24 ET | 200 | 1.275 |
| 02:26 ET | 100 | 1.275 |
| 02:40 ET | 2491 | 1.275 |
| 02:42 ET | 887 | 1.275 |
| 02:44 ET | 400 | 1.275 |
| 02:45 ET | 277 | 1.275 |
| 02:47 ET | 100 | 1.275 |
| 02:56 ET | 100 | 1.275 |
| 03:00 ET | 7500 | 1.285 |
| 03:02 ET | 300 | 1.285 |
| 03:07 ET | 1200 | 1.285 |
| 03:09 ET | 200 | 1.285 |
| 03:12 ET | 100 | 1.285 |
| 03:14 ET | 100 | 1.285 |
| 03:16 ET | 100 | 1.285 |
| 03:18 ET | 1300 | 1.2856 |
| 03:20 ET | 200 | 1.285 |
| 03:21 ET | 100 | 1.285 |
| 03:23 ET | 100 | 1.285 |
| 03:25 ET | 392 | 1.285 |
| 03:27 ET | 1738 | 1.285 |
| 03:30 ET | 9022 | 1.2598 |
| 03:32 ET | 526 | 1.2599 |
| 03:34 ET | 300 | 1.2501 |
| 03:36 ET | 400 | 1.255 |
| 03:38 ET | 100 | 1.255 |
| 03:39 ET | 200 | 1.255 |
| 03:41 ET | 100 | 1.255 |
| 03:43 ET | 917 | 1.255 |
| 03:45 ET | 4825 | 1.255 |
| 03:48 ET | 200 | 1.255 |
| 03:50 ET | 300 | 1.255 |
| 03:52 ET | 600 | 1.255 |
| 03:54 ET | 500 | 1.255 |
| 03:56 ET | 1717 | 1.2599 |
| 03:57 ET | 700 | 1.255 |
| 03:59 ET | 12204 | 1.255 |
Apr 24, 2024
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K, from 4:51PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:51PM ET on Wednesday Apr 24, 2024 by Dow JonesOcean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K, from 4:51PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:51PM ET on Wednesday Apr 24, 2024 by Dow Jones
Mar 28, 2024
Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL, from 8:01AM ET on Thursday Mar 28, 2024 by Dow Jones
8:01AM ET on Thursday Mar 28, 2024 by Dow JonesOcean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL, from 8:01AM ET on Thursday Mar 28, 2024 by Dow Jones
8:01AM ET on Thursday Mar 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ocean Biomedical Inc | 49.0M | -0.9x | --- |
Eledon Pharmaceuticals Inc | 48.9M | -1.1x | --- |
Genenta Science SPA | 46.5M | -4.3x | --- |
Checkpoint Therapeutics Inc | 51.4M | -0.5x | --- |
Gain Therapeutics Inc | 51.7M | -1.8x | --- |
IN8BIO, Inc. | 45.9M | -1.0x | --- |
Company Information
Ocean Biomedical Holdings, Inc., formerly Ocean Biomedical, Inc., is a United States-based biopharmaceutical company. The Company is focused on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. In oncology, it is developing a mono-specific and two bi-specific humanized monoclonal antibodies (mAb), product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer (NSCLC) and glioblastoma multiforme (GBM). In fibrosis, it is developing a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) and Hermansky-Pudlak Syndrome (HPS). It has three product candidates: a malaria vaccine candidate targeting either or both of Plasmodium falciparum schizont egress antigen (PfSEA-1), and parasite antigen Plasmodium falciparum glutamic-acid-rich protein(PfGARP); a humanized mAb malaria therapeutic candidate targeting PfGARP; and a small molecule malaria therapeutic candidate.
Contact Information
- Headquarters
- 55 Claverick Street, Room 212PROVIDENCE, RI, United States 02903
- Phone
- 401-444-7375
- Fax
- 302-655-5049
Executives
- Executive Chairman, Co-Founder
- Chirinjeev Kathuria
- Chief Executive Officer
- Elizabeth Ng
- Chief Financial Officer
- Gurinder Kalra
- Chief Accounting Officer
- Robert Sweeney
- Vice President - Strategic Partnerships
- Sharon Talcott
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $49.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 34.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.40 |
Book Value | $-0.06 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
